Researchers at CNRS, Université Côte d’Azur and Inserm have demonstrated a new mechanism related to the onset of migraine. In fact, they found how a mutation, causes dysfunction in a protein which inhibits neuronal electrical activity, induces migraines. These results, published in Neuron on December 17, 2018, open a new path for the development of anti-migraine medicines.
Even though 15% of the adult population worldwide suffers from migraines, no long-term, effective, curative treatment has been marketed to date. Migraine episodes are related, among other factors, to electric hyperexcitability in sensory neurons. Their electrical activity is controlled by proteins that generate current called ion channels, specifically by the TRESK channel, which inhibits electrical activity. The researchers have shown that a mutation in the gene encoding for this protein causes a split between two dysfunctional proteins: one is inactive and the other targets other ion channels (K2P2.1) inducing a great stimulation of the neuronal electrical activity causing migraines.
Though researchers had already shown the hereditary nature of migraines, they did not know the mechanism underlying migraine. By demonstrating that the TRESK split induces hyperexcitability in sensory neurons leading to migraine, this work, carried out at the Institut de Biologie Valrose (CNRS/Inserm/Université Côte d’Azur), opens new research path for the development of anti-migraine medicines. A patent application has been filed 1 : the scope is targeting K2P2.1 channels to reduce the electrical activity of neurons and prevent migraines from being triggered.
What is more, the researchers propose that this new genetical mechanism, causing the formation of two proteins instead of just one, has now to be considered for the study of other genetic diseases and for diagnosing them.
1 Patent PCT/EP2018/067581 “Methods and compositions for treating migraine”
Bibliography:
Migraine-associated TRESK mutations increase neuronal excitability through alternative translation initiation and inhibition of TREK. Perrine Royal, Alba Andres-Bilbe, Pablo Ávalos Prado, Clément Verkest, Brigitte Wdziekonski, Sébastien Schaub, Anne Baron, Florian Lesage, Xavier Gasull, Joshua Levitz, Guillaume Sandoz, Neuron , December 17, 2018.- 21 december 2018
Vascular development : finding the right itinerary - 17 december 2018
Discovery of novel mechanisms that cause migraines - 10 december 2018
Joint call for swift and just climate action the Katowice Memorandum - 7 December 2018
France-United States space cooperation - French science instrument on InSight ’hears’ sound of Martian winds for the first time - 6 December 2018
Silicosis is on the rise, but is there a therapeutic target ? - December 5, 2018
Pollution : New ammonia emission sources detected from space - 5 december 2018
France-United States space cooperation - InSight Mars exploration mission - First tests of French SEIS seismometer successful - 29 November 2018
A prosthetic arm that decodes phantom limb movements
